Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Neuroprotective Role of the Neuronal PAS Domain-Containing Protein 4 (NPAS4) Transcription Factor in MS-Related Neuroinflammation and Degeneration.
FY 2021-22
Summary
Multiple sclerosis (MS), a disabling disease of the brain and spinal cord, affects more than 100,000 Canadians and over 2.5 million people worldwide. It is caused by loss of myelin, the protective covering of nerve cells, and the nerve fibers protected by myelin, resulting in weakness/paralysis, fatigue, and cognitive impacts that reduce quality of life. While disease worsening is thought to be caused by loss of neurons due to immune cells, approved treatments focused on deleting immune cells come with major risks. This highlights the importance of identifying factors that act more directly to protect myelin and neurons in settings where immune cells cause trouble. Previous work in our lab suggests such a role for NPAS4, a key protein in the brain involved in neuronal health and survival, as NPAS4 levels drop when mice are most affected in an animal model of MS. NPAS4 deletion in cells and mice was also found to protect against disease while increasing its expression worsened disease. This project aims to further our understanding of the protective properties of NPAS4 in MS. First, we will examine how NPAS4 levels change at disease onset, recovery, and worsening in an animal model of MS. Next, immune cells and their products known to play a role in MS processes will be studied to see how or if they change NPAS4 levels. Lastly, NPAS4 will be deleted or increased in neurons to see how it affects their function and survival and NPAS4 will be deleted in our MS animal model at different disease stages to determine when it most influences clinical disease. By improving our understanding of NPAS4s neuroprotective properties, this project may contribute to the creation of NPAS4-targeting drugs to limit disease worsening and improve the quality of life of individuals with MS.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
467094
Name
Abdul-Rahman Raneen
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Neuroprotective Role of the Neuronal PAS Domain-Containing Protein 4 (NPAS4) Transcription Factor in MS-Related Neuroinflammation and Degeneration.
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Multiple Sclerosis; Neurodegeneration; Neuroimmunology; Neuroinflammation; Neuroprotection; Transcription Factor
Abstract
Multiple sclerosis (MS), a disabling disease of the brain and spinal cord, affects more than 100,000 Canadians and over 2.5 million people worldwide. It is caused by loss of myelin, the protective covering of nerve cells, and the nerve fibers protected by myelin, resulting in weakness/paralysis, fatigue, and cognitive impacts that reduce quality of life. While disease worsening is thought to be caused by loss of neurons due to immune cells, approved treatments focused on deleting immune cells come with major risks. This highlights the importance of identifying factors that act more directly to protect myelin and neurons in settings where immune cells cause trouble. Previous work in our lab suggests such a role for NPAS4, a key protein in the brain involved in neuronal health and survival, as NPAS4 levels drop when mice are most affected in an animal model of MS. NPAS4 deletion in cells and mice was also found to protect against disease while increasing its expression worsened disease. This project aims to further our understanding of the protective properties of NPAS4 in MS. First, we will examine how NPAS4 levels change at disease onset, recovery, and worsening in an animal model of MS. Next, immune cells and their products known to play a role in MS processes will be studied to see how or if they change NPAS4 levels. Lastly, NPAS4 will be deleted or increased in neurons to see how it affects their function and survival and NPAS4 will be deleted in our MS animal model at different disease stages to determine when it most influences clinical disease. By improving our understanding of NPAS4s neuroprotective properties, this project may contribute to the creation of NPAS4-targeting drugs to limit disease worsening and improve the quality of life of individuals with MS.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Abdul-Rahman, Raneen
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~